(Q55063992)

16 June 2018

title

Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study. (English)

1 reference

16 June 2018

1 reference

parkinsonian syndrome

1 reference

4

Gurwitz JH

1 reference

16 June 2018

Rhonda Bohn

2

object named as

Bohn RL

1 reference

16 June 2018

Jerry Avorn

1

object named as

Avorn J

1 reference

16 June 2018

Helen Mogun

3

object named as

Mogun H

1 reference

16 June 2018

author name string

Monane M

5

1 reference

16 June 2018

Everitt D

6

1 reference

16 June 2018

Walker A

7

1 reference

16 June 2018

language of work or name

English

0 references

publication date

1 July 1995

1 reference

16 June 2018

American Journal of Medicine

published in

1 reference

16 June 2018

volume

99

1 reference

16 June 2018

issue

1

1 reference

16 June 2018

page(s)

48-54

1 reference

16 June 2018

A metaanalysis of controlled trials of neuroleptic treatment in dementia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980104-1

Neuroleptics and the Elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980104-1

Psychotropic drug practice in nursing homes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980104-1

Psychoactive medication use in intermediate-care facility residents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980104-1

A study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980104-1

A survey of drug-induced extrapyramidal reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980104-1

Drug-Induced Parkinsonism and Idiopathic Parkinson's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980104-1

Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980104-1

Prognosis of drug-induced Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980104-1

Medicaid data as a resource for epidemiologic studies: strengths and limitations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980104-1

Use of Medicaid data for pharmacoepidemiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980104-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980104-1

Underrecognition of tardive dyskinesia and drug-induced parkinsonism by psychiatric residents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980104-1

Drug-induced parkinsonism in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980104-1

The pathophysiology of extrapyramidal side-effects of neuroleptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980104-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(99)80104-1

1 reference

16 June 2018

PubMed ID

7598142

1 reference

16 June 2018